MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

被引:17
|
作者
Huang, Qingli [1 ]
Hou, Sen [2 ]
Zhu, Xiuqing [3 ]
Liu, Shouzhou [1 ]
机构
[1] Liaocheng Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China
[2] Yanggu Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
[3] Chiping Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
关键词
miR-192; Nasopharyngeal carcinoma; RB1; PI3K; AKT pathway; CELL-PROLIFERATION; RETINOBLASTOMA PROTEIN; MIR-192; SUPPRESSES; TUMOR-SUPPRESSOR; CANCER CELLS; METASTASIS; INVASION; GROWTH; APOPTOSIS; PROGRESSION;
D O I
10.1186/s12957-020-1798-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression. Methods The expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays. Results The expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC. Conclusion miR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway
    Qu, Yi
    He, Ying
    Ruan, Hanjin
    Qin, Lizheng
    Han, Zhengxue
    CANCER MEDICINE, 2023, 12 (05): : 5781 - 5797
  • [32] MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway
    Zhang, Wei
    Zhang, Qiu
    Cui, Qianbo
    Xu, Yu
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
  • [33] MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway
    Zhang, Wei
    Zhang, Qiu
    Cui, Qianbo
    Xu, Yu
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
  • [34] MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
    Tu, Kangsheng
    Liu, Zhikui
    Yao, Bowen
    Han, Shaoshan
    Yang, Wei
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 965 - 974
  • [35] Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
    Sun, Jiachen
    Zhao, Hongqing
    Shen, Chuan'an
    Li, Shiyi
    Zhang, Wen
    Ma, Jinglong
    Li, Zhisheng
    Zhang, Ming
    Yang, Jianqiu
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [36] Tideglusib promotes wound healing in aged skin by activating PI3K/Akt pathway
    Jiachen Sun
    Hongqing Zhao
    Chuan’an Shen
    Shiyi Li
    Wen Zhang
    Jinglong Ma
    Zhisheng Li
    Ming Zhang
    Jianqiu Yang
    Stem Cell Research & Therapy, 13
  • [37] Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway
    Liu, Shu-Qing
    Zhang, Ming-Liang
    Zhang, HUi-Jun
    Liu, Fang-Zhou
    Chu, Rao-Juan
    Zhang, Guang-Xian
    Zhu, Lin
    LIFE SCIENCES, 2017, 180 : 36 - 41
  • [38] MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway
    Dong, Yongqiang
    Liang, Guojun
    Yuan, Bo
    Yang, Chaoqun
    Gao, Rui
    Zhou, Xuhui
    TUMOR BIOLOGY, 2015, 36 (03) : 1477 - 1486
  • [39] MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway
    Zhidong Zhao
    Xianju Qin
    Scientific Reports, 10
  • [40] MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway
    Zhao, Zhidong
    Qin, Xianju
    SCIENTIFIC REPORTS, 2020, 10 (01)